Share

May 22, 2012; 78 (21) Articles

Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy

Z. Zhao, A. Hashiguchi, J. Hu, Y. Sakiyama, Y. Okamoto, S. Tokunaga, L. Zhu, H. Shen, H. Takashima
First published May 9, 2012, DOI: https://doi.org/10.1212/WNL.0b013e3182574f8f
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
392

Share

Article Information

vol. 78 no. 21 1644-1649
DOI: 
https://doi.org/10.1212/WNL.0b013e3182574f8f
PubMed: 
22573628
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received October 18, 2011
  • Accepted January 23, 2012
  • First Published May 9, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Z. Zhao, MS,
    2. A. Hashiguchi, MD,
    3. J. Hu, MD, PhD,
    4. Y. Sakiyama, MD, PhD,
    5. Y. Okamoto, MD, PhD,
    6. S. Tokunaga, MD,
    7. L. Zhu, MB,
    8. H. Shen, MS and
    9. H. Takashima, MD, PhD
  1. Z. Zhao, MS,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. A. Hashiguchi, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. J. Hu, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Y. Sakiyama, MD, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Y. Okamoto, MD, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. S. Tokunaga, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. L. Zhu, MB,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. H. Shen, MS and
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. H. Takashima, MD, PhD
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Received speaker honoraria from Kyushu University, GlaxoSmithKline, Bayer, Eisaico., Novartis, Tanabe Mitsubishi, Biogen Idec, Benesis co., Takeda, Teijin, Pfizer, and Dainippon Sumitomo Pharma

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Receive consulting fees from Teijin;

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Funded by the Japanese Ministry of Health, Welfare, and Labor Research Committee for Charcot–Marie–Tooth Disease (2010-present), Ataxic disease; , Applying Health Technology; , the Ministry of Education, Culture, Sports, Science, and Technology of Japan. government granting agency grant 21591095(2009-present)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. Royalty from the Athena diagnostics (2003-present)

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neuromuscular Disease (Z.Z., J.H., H.S.) and Electromyography (L.Z.), Third Hospital of Hebei Medical University, Shijiazhuang, PR China; and Department of Neurology and Geriatrics (A.H., Y.S., Y.O., S.T., H.T.), Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  1. Correspondence & reprint requests to Dr. Hu: jinghujp{at}yahoo.com.cn
View Full Text

Article usage

Article usage: May 2012 to April 2023

AbstractFullPdfSource
May 201212581534Highwire
Jun 2012282911Highwire
Jul 201213067Highwire
Aug 20127267Highwire
Sep 20129115Highwire
Oct 20122857Highwire
Nov 20125745Highwire
Dec 20122834Highwire
Jan 20134244Highwire
Feb 20132812Highwire
Mar 20133513Highwire
Apr 20134001Highwire
May 20134375Highwire
Jun 20132211Highwire
Jul 20133311Highwire
Aug 20132800Highwire
Sep 2013911Highwire
Oct 20132801Highwire
Nov 20132225Highwire
Dec 20132611Highwire
Jan 20142021Highwire
Jan 2014075pmc
Feb 20141512Highwire
Mar 20142710Highwire
Apr 20142222Highwire
May 20142125Highwire
Jun 20141722Highwire
Jul 20142111Highwire
Aug 20141413Highwire
Sep 20141400Highwire
Oct 20141311Highwire
Nov 20141600Highwire
Dec 20141210Highwire
Jan 20151600Highwire
Jan 201501611pmc
Feb 20151110Highwire
Feb 20150119pmc
Mar 20152000Highwire
Mar 2015085pmc
Apr 20151322Highwire
Apr 20150105pmc
May 20151200Highwire
May 2015077pmc
Jun 20151100Highwire
Jun 20150127pmc
Jul 20151522Highwire
Jul 2015085pmc
Aug 20152810Highwire
Aug 20150105pmc
Sep 20151510Highwire
Sep 201501311pmc
Oct 20152400Highwire
Oct 2015053pmc
Nov 20152010Highwire
Nov 2015087pmc
Dec 20151610Highwire
Dec 2015063pmc
Jan 20162212Highwire
Jan 2016062pmc
Feb 2016700Highwire
Feb 2016022pmc
Mar 20161300Highwire
Mar 2016042pmc
Apr 20161621Highwire
Apr 2016067pmc
May 20161911Highwire
May 201601010pmc
Jun 20161722Highwire
Jun 2016083pmc
Jul 20161110Highwire
Jul 2016062pmc
Aug 20161711Highwire
Aug 2016072pmc
Sep 20161810Highwire
Sep 20160107pmc
Oct 20162100Highwire
Oct 2016083pmc
Nov 20161610Highwire
Nov 2016062pmc
Dec 20161210Highwire
Dec 2016061pmc
Jan 20171300Highwire
Jan 2017052pmc
Feb 20171400Highwire
Feb 201701814pmc
Mar 20171600Highwire
Mar 2017042pmc
Apr 20171101Highwire
Apr 2017066pmc
May 2017900Highwire
May 2017111pmc
Jun 2017300Highwire
Jun 2017785pmc
Jul 2017311Highwire
Jul 2017466pmc
Aug 2017612Highwire
Aug 2017242pmc
Sep 2017602Highwire
Sep 2017233pmc
Oct 2017700Highwire
Oct 201751313pmc
Nov 20171000Highwire
Nov 201761010pmc
Dec 2017900Highwire
Jan 20181800Highwire
Feb 20181310Highwire
Mar 2018800Highwire
Apr 20181700Highwire
Apr 201821317pmc
May 2018901Highwire
Jun 2018500Highwire
Jun 201831012pmc
Jul 20181300Highwire
Aug 20181400Highwire
Aug 2018245pmc
Sep 20181711Highwire
Oct 2018821Highwire
Nov 20181510Highwire
Dec 20181901Highwire
Jan 2019421Highwire
Feb 20191300Highwire
Mar 2019311Highwire
Apr 20191113Highwire
May 2019800Highwire
Jun 20191502Highwire
Jul 2019800Highwire
Aug 2019500Highwire
Sep 2019600Highwire
Oct 20196011Highwire
Nov 20192911Highwire
Dec 2019901Highwire
Jan 20202500Highwire
Feb 2020900Highwire
Mar 2020800Highwire
Apr 20201100Highwire
May 20201610Highwire
Jun 20201712Highwire
Jul 20201500Highwire
Aug 20201601Highwire
Sep 20201501Highwire
Oct 20201100Highwire
Nov 20201310Highwire
Dec 20202100Highwire
Jan 20211100Highwire
Feb 20211401Highwire
Mar 20211600Highwire
Apr 20211800Highwire
May 20211411Highwire
Jun 2021800Highwire
Jul 20211900Highwire
Aug 20212310Highwire
Sep 20212300Highwire
Oct 20211700Highwire
Nov 20211511Highwire
Dec 20211000Highwire
Jan 20221100Highwire
Feb 20222300Highwire
Mar 20223100Highwire
Apr 20221200Highwire
May 20223700Highwire
Jun 20222011Highwire
Jul 20221001Highwire
Aug 20221300Highwire
Sep 20221420Highwire
Oct 20222903Highwire
Nov 20223200Highwire
Dec 20221811Highwire
Jan 20232311Highwire
Feb 20231100Highwire
Mar 20231011Highwire
Apr 20231310Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles